ArticleJournal of advanced research2025

Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction.

Jiehuang Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.